Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
65,36 USD | +0,63% | -0,18% | +18,53% |
Attività
Numero di dipendenti: 642
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Generics, Established Brands, and Other
77,0
%
| 275 | 86,8 % | 375 | 77,0 % | +36,40% |
Rare Disease
23,0
%
| 42 | 13,2 % | 112 | 23,0 % | +168,95% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
99,9
%
| 312 | 98,7 % | 486 | 99,9 % | +55,64% |
Canada
0,1
%
| 4 | 1,3 % | 1 | 0,1 % | -85,73% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08/09/20 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 06/05/16 |
Patrick Walsh
CHM | Chairman | 63 | 17/05/18 |
Elizabeth Powell
CMP | Compliance Officer | - | 24/02/22 |
Mary Pao
CTO | Chief Tech/Sci/R&D Officer | - | 24/02/22 |
Chief Tech/Sci/R&D Officer | 56 | 19/11/21 | |
James Marken
COO | Chief Operating Officer | 61 | 01/03/07 |
Krista Davis
HRO | Human Resources Officer | 51 | 12/09/22 |
Meredith Cook
LAW | General Counsel | 50 | 18/07/22 |
Ori Gutwerg
PRN | Corporate Officer/Principal | 50 | 01/02/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 01/05/18 |
Antonio Pera
BRD | Director/Board Member | 66 | 06/08/20 |
David Nash
BRD | Director/Board Member | 68 | 01/10/18 |
Patrick Walsh
CHM | Chairman | 63 | 17/05/18 |
Renee Tannenbaum
BRD | Director/Board Member | 72 | 22/03/22 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 06/08/20 |
Chief Tech/Sci/R&D Officer | 56 | 19/11/21 | |
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08/09/20 |
Matthew Leonard
BRD | Director/Board Member | 58 | 21/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 10 864 | 0 | 0 | 80,64 % |
Azione B | 1 | 21 332 065 | 17 211 113 ( 80,68 %) | 263 943 ( 1,237 %) | |
Azione C | 0 | 25 000 | 0 | 0 |
Coordinate società
ANI Pharmaceuticals, Inc.
210 Main Street West
56623, Baudette
+218 634 3500
http://www.anipharmaceuticals.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,53% | 1,37 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione ANIP
- Società ANI Pharmaceuticals, Inc.